Laboratory Catalog Page 4 Laboratory Overview

4 Laboratory Overview The Challenges The 21st century has brought unprecedented medical advances, and those advances are continually changing the way we diagnose, treat and cure disease. But change does not come without its challenges. For laboratories, the rising tide of samples has put increased scrutiny on the way you identify, track and report samples. Hand-written labels lead to lost or misinterpreted Information. Brady printed labels provide crisp, clear and readable information. Stunning Stats: Despite being an industry of precision, more than 85% of laboratories in the U.S. are still relying on Sharpies or Excel spreadsheets for sample management. In a survey of 350 scientists, nearly 60% reported having lost samples due to label failure. Regulatory Agency Policy The Joint Commission National Patient Safety Goals (NPSG 01.01.01) College of American Pathologists Quality Management Plan Clinical & Laboratory Standards Institute (CLSI) AUTO12-A Clinical Laboratory Improvement Amendment (CLIA) 42 ISC 263A Centers for Disease Control (CDC) Laboratory Best Practices ISBN 1-56238-748-0 National Cancer Institute (NCI) Best Practices for Biospecimen (ID B.6.2) Food and Drug Administration (FDA) GLP 21. CFR Part 56 Sample Management Regulators Numerous regulators, funders and accrediting agencies have heightened their policies on sample management. The new regulations are centered on one primary goal: help your lab mitigate or eliminate sample loss. Handwritten Labels vs. Printed Labels Difficult to read Smears when handled Limited writing space Fades over time when stored Erased by chemicals Clear, crisp and readable Will not smear nor fade Barcodes hold large amounts of information Durability and resistance to chemicals Cost of Label Failure We recently surveyed 350 scientists about their sample management processes. Nearly 60% of them reported having occasionally lost samples due to label failure, and almost half of those reported the loss impacted more than 2% of their samples. Loss means different things across various types of labs, from a minor inconvenience to major devastation. In a clinical setting, sample loss can lead to misdiagnosis, delays in diagnosis or even fatalities and law suits. In a pharmaceutical environment, it can postpone or halt drug development and production. In an academic laboratory, it can impair -or even void - your findings. In an biotechnology setting, it can compromise your quality control, data integrity, or drug safety. It also opens the door for the possibility of intellectual property loss or delay in technology and product. In any of these situations, a single sample loss can mean critical data or information will have to be reproduced-putting millions of dollars at risk.

Previous Page
Next Page